2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 569.273 | 598.587 | 536.582 | 574.621 | 613.781 | 730.954 | 811.883 | 685.631 | 613.860 | 576.057 |
Total Income - EUR | 596.215 | 621.418 | 565.048 | 592.808 | 656.415 | 751.783 | 833.112 | 732.413 | 633.434 | 589.407 |
Total Expenses - EUR | 551.039 | 506.134 | 522.023 | 569.441 | 645.420 | 734.706 | 769.875 | 640.640 | 609.398 | 712.219 |
Gross Profit/Loss - EUR | 45.175 | 115.283 | 43.025 | 23.367 | 10.995 | 17.077 | 63.238 | 91.773 | 24.036 | -122.812 |
Net Profit/Loss - EUR | 37.305 | 96.809 | 35.416 | 18.269 | 4.445 | 9.559 | 57.058 | 84.595 | 17.828 | -126.651 |
Employees | 14 | 15 | 16 | 15 | 15 | 13 | 13 | 11 | 9 | 9 |
Check the financial reports for the company - Helianthus Pharm Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 17.515 | 16.712 | 14.628 | 15.218 | 30.019 | 31.023 | 25.344 | 37.411 | 57.550 | 41.431 |
Current Assets | 266.482 | 352.970 | 172.751 | 194.915 | 182.564 | 222.824 | 297.552 | 266.186 | 215.996 | 120.016 |
Inventories | -20.720 | 36.023 | 60.167 | 77.478 | 61.261 | 13.882 | 12.531 | 39.247 | 76.731 | 36.450 |
Receivables | 104.052 | 64.660 | 13.900 | 86.536 | 116.589 | 95.313 | 183.556 | 89.027 | 136.099 | 70.218 |
Cash | 183.151 | 252.286 | 98.684 | 30.901 | 4.713 | 113.630 | 101.465 | 137.911 | 3.167 | 13.348 |
Shareholders Funds | 101.531 | 199.187 | 35.597 | 18.446 | 22.552 | 31.675 | 57.225 | 76.640 | 17.992 | -126.487 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 182.467 | 170.494 | 151.782 | 191.687 | 190.031 | 222.173 | 265.836 | 227.119 | 255.554 | 288.156 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4773 - 4773" | |||||||||
CAEN Financial Year |
4773
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Helianthus Pharm Srl